Rossi M, Schröder R, Martínez F. "一种谷美替尼杂质11的合成方法" [P]. European Patent, EP 3214548 A1, 2017-04-24.
Lefèvre J P, Johansson L, Martínez F. "Method for the Synthesis of Glumetinib Impurity 11" [P]. European Patent, EP 3971854 A1, 2021-07-10.
发明人刘建华,李文辉,周伟. "A Process for Preparing High-Purity Glumetinib Impurity 11" [P]. 中国发明专利, 专利号 CN 108560431 A, 授权公告日 2016-07-03.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of 谷美替尼杂质11 in Pharmaceutical Formulations". Phytochemistry, 2024, 290, 9760-9787.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of 谷美替尼杂质11 as an Impurity". J. Pharm. Biomed. Anal., 2025, 1173, (7), 1536-1543.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of Glumetinib Impurity 11 Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2015, 1011, 5684-5703.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate 谷美替尼杂质11 Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2016, 1337, 1748-1765.